Placebo and Homeopathy

Thank you for your article "From Placebo to Homeopathy: The Fear of the Irrational" (D. Viza, The Scientist, 12[18]:8, Sept. 14, 1998). I can fully endorse Viza's position, from a clinical and psychological perspective. The whole placebo issue is a reflection of a paradigmatic impasse: Our therapeutic endeavors rest on the unreflected presupposition that only causally specific, hence biochemically specifiable and explainable, interventions are scientifically warranted. While this certainly is

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Thank you for your article "From Placebo to Homeopathy: The Fear of the Irrational" (D. Viza, The Scientist, 12[18]:8, Sept. 14, 1998). I can fully endorse Viza's position, from a clinical and psychological perspective. The whole placebo issue is a reflection of a paradigmatic impasse: Our therapeutic endeavors rest on the unreflected presupposition that only causally specific, hence biochemically specifiable and explainable, interventions are scientifically warranted.

While this certainly is one viable perspective, this approach neglects the fact that the organism, a very complex and probably autopoietic system, acts, in part, self-directed. This entails that any causal intervention leads to a cascade of correcting answers, besides the intended causal action. Other systems of healing, like homeopathy or maybe other complementary and native healing systems, rely on the triggering of the systemic self-healing response, which probably is a complex redirection of the system's balance. This might be brought about in many ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Harald Walach

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution